StocksMedium•19 November 2026•
1 min read
Co-Diagnostics Announces 1-for-25 Reverse Stock Split
Key Facts
1Co-Diagnostics announced a 1-for-25 reverse stock split of its common stock to become effective on Nov. 24.
Co-Diagnostics announced a 1-for-25 reverse stock split of its common stock to become effective on November 24, 2026. Seeking Alpha reported that the move is intended to enable the company to maintain compliance with exchange listing requirements.
The company is implementing the reverse split to increase the per-share market price of its common stock. CODX closed at $0.1977 on November 18, 2026, after reaching a day high of $0.2249 and a low of $0.1842 during the session.